Reversible disruption of a wavelength discrimination in pigeons following administration of pheniprazine
- 1 November 1964
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 6 (6) , 690-695
- https://doi.org/10.1016/0041-008x(64)90119-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Amblyopia Due to PheniprazineBMJ, 1963
- Toxic Amblyopia due to PheniprazineBMJ, 1963
- TOXIC AMBLYOPIA DURING ANTIDEPRESSANT TREATMENT WITH PHENIPRAZINE (CATRAN®)Acta Psychiatrica Scandinavica, 1962
- NEUROPATHOLOGIC LESIONS IN DOGS AFTER PROLONGED ADMINISTRATION OF PHENYLISOPROPYLHYDRAZINE (JB 516) AND PHENYLISOBUTYLHYDRAZINE (JB 835)1962
- NEUROLOGIC, NEUROPATHOLOGIC, AND NEUROCHEMICAL EFFECTS OF PROLONGED ADMINISTRATION OF PHENYLISOPROPYLHYDRAZINE (JB 516), PHENYLISOBUTYLHYDRAZINE (JB 835), AND OTHER MONOAMINE OXIDASE INHIBITORS1962
- Toxic Amblyopia Caused by Pheniprazine Hydrochloride (JB-516, Catron)Archives of Ophthalmology (1950), 1961
- Effects of discrimination training on stimulus generalization.Journal of Experimental Psychology, 1959
- The application of a monoamine-oxidase inhibitor, 1-phenyl-2-hydrazinopropane (JB-516), to the treatment of primary hypertensionAmerican Heart Journal, 1959